News & Updates
Showing Multidisciplinary articles
Showing
Show Multimedia Only

Real-world ES SCLC outcomes comparable between phase I trial participation and SoC
24 Jul 2026
byNatalia Reoutova
A single-centre retrospective observational study of 90 patients from Australia with extensive-stage small cell lung cancer (SCLC) shows that phase I clinical trial participation has acceptable safety and survival outcomes comparable to those of standard-of-care (SoC) treatment.








